Blog articles
Discover new insights for your clinical trials in Clario’s expansive library of scientifically-driven blog articles, penned by the industry key opinion leaders (KOLs) of our science team.
Case studies
Learn more about how we have helped sponsors, sites, and CROs through 870 regulatory approvals.
Downloads
Explore Clario’s catalog of downloadable white papers, eBooks, fact sheets and more to uncover rich insights that can bolster your clinical trial performance.
Recent downloads
Cognitive Assessment and Wearable Sensor-Based Gait and Balance Assessment in Studies of Alzheimer’s Disease and Mild Cognitive Impairment: A Preliminary Review
OPAL V2R® technical specifications
eCOA Zoom In/Zoom Out
Optimal Digital Endpoint Selections of Movement in Parkinson’s disease
Events
We love meeting clients, sponsors and patients. We look forward to seeing you. Here’s where we will be.
Next event
In-person Event
AD/PD 2025
AD/PD spotlights the field of neurodegenerative diseases for global medical & scientific professionals. It covers advances in science and therapy of Alzheimer’s and Parkinson’s Diseases and related neurological disorders
April 1, 2025 – April 5, 2025
Latest external publications
Dive into Clario’s extensive library of peer-reviewed and trade publications, written by the industry-recognized key opinion leaders (KOLs) of our science team.
The Future Fit of Wearables for Patient-Centric Clinical Trials
Five Critical Qualities for Identifying a Partner to Globally Scale Ophthalmology Clinical Trials
New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA-Approved Drugs and Biologics
Webinars
Join Clario’s industry-leading science team and discover the latest trends and practical optimizations for clinical trials in our growing webinar replay library.
Next webinar
Webinar Event
From Symptoms to Solutions: Enhancing Interstitial Lung Disease (ILD) Trials with Next-Gen Assessments
Register for this webinar to learn about the latest advancements in ILD clinical trial design from endpoint selection and novel cough monitoring tech to patient-centric trial design and imaging solutions.
April 22, 2025
Latest webinar replays
GLP-1 Agonist Development: Endpoint Strategies to Help Differentiate Your Drug Webinar Replay
Innovation in QT Strategies: Leveraging Early-stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver Webinar Replay
Optimizing Obesity Trials: Integrating Diverse Endpoints to Holistically Assess Safety and Efficacy of GLP-1 Agonists and Beyond Webinar Replay
Psychiatric Drug Development: Digital Endpoint Solutions to Extract the Most Value from Your Clinical Study Webinar Replay
